Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study

Follicular lymphoma (FL) is the most common type of indolent non-Hodgkin lymphoma. Despite treatment advances that have improved outcomes for patients with relapsed or refractory (R/R) FL, many patients still die from progressive disease or treatment-related toxicities. In the phase Ib/II GO29365 s...

Полное описание

Библиографические подробности

Главные авторы:	Christopher R. Flowers, Matthew J. Matasar, Alex F. Herrera, Mark Hertzberg, Sarit Assouline, Judit Demeter, Andrew McMillan, Amitkumar Mehta, Stephen Opat, Marek Trnňný, Lisa Musick, Jamie Hirata, Annie Yang, Laurie H. Sehn
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Ferrata Storti Foundation 2023-09-01
Серии:	Haematologica
Online-ссылка:	https://haematologica.org/article/view/11281
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!